Motif Neurotech
TX - HoustonBiotechnology
Focus: Motif Neurotech is a Houston-based pre-revenue biotech developing the Motif XCS System, a wireless brain implant for treatment-resistant depression. The company operates at early clinical stage with a micro-scale team focused on novel neuromodulation.
Profile data last refreshed 17h ago · AI intelligence enriched 3w ago
Employees
1-50
Open Jobs
0
About Motif Neurotech
AI assessmentNot HiringNo open roles listed right now. Follow Motif Neurotech to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Motif Neurotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Motif XCS System
Major Depressive DisorderRecent News · Motif Neurotech(10)
Help build intelligence for Motif Neurotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.